ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $431,486 | -43.2% | 12,100 | -59.5% | 0.00% | -50.0% |
Q1 2023 | $759,460 | +6.4% | 29,900 | +69.9% | 0.00% | 0.0% |
Q4 2022 | $713,856 | +105.1% | 17,600 | +67.6% | 0.00% | +100.0% |
Q3 2022 | $348,000 | -19.4% | 10,500 | -14.6% | 0.00% | 0.0% |
Q2 2022 | $432,000 | -68.7% | 12,290 | -59.0% | 0.00% | -80.0% |
Q1 2022 | $1,378,000 | -28.7% | 29,943 | +2.7% | 0.01% | -16.7% |
Q4 2021 | $1,933,000 | +89.9% | 29,148 | +78.8% | 0.01% | +100.0% |
Q3 2021 | $1,018,000 | +167.2% | 16,300 | +254.3% | 0.00% | +200.0% |
Q2 2021 | $381,000 | -56.2% | 4,600 | -64.9% | 0.00% | -75.0% |
Q1 2021 | $870,000 | -51.8% | 13,124 | -44.2% | 0.00% | -50.0% |
Q4 2020 | $1,804,000 | +239.7% | 23,500 | +91.1% | 0.01% | +100.0% |
Q2 2020 | $531,000 | +40.1% | 12,300 | -6.7% | 0.00% | +100.0% |
Q1 2020 | $379,000 | -9.1% | 13,189 | +100.7% | 0.00% | -33.3% |
Q4 2019 | $417,000 | +82.9% | 6,571 | -18.9% | 0.00% | +50.0% |
Q3 2019 | $228,000 | -50.0% | 8,100 | -52.9% | 0.00% | -50.0% |
Q2 2019 | $456,000 | +63.4% | 17,200 | -23.6% | 0.00% | +100.0% |
Q4 2018 | $279,000 | -2.8% | 22,500 | +50.5% | 0.00% | 0.0% |
Q3 2018 | $287,000 | +523.9% | 14,947 | -39.2% | 0.00% | – |
Q1 2017 | $46,000 | – | 24,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |